SILVANA PANNAIN
Silvana Pannain’s biography WOC June 2024
Dr. Silvana Pannain is an Associate Professor of Endocrinology, Diabetes, and
Metabolism at the University of Chicago, where she serves as the Obesity Medicine
Director for the Center for Weight and Metabolic Health. Dr. Pannain's research focuses
on the interplay between sleep and meal timing, obesity, glucose homeostasis, and
appetite regulation. More recently, she has been conducting clinical trials with novel
anti-obesity drugs.
Dr. Silvana Pannain is an Associate Professor of Endocrinology, Diabetes, and
Metabolism at the University of Chicago, where she serves as the Obesity Medicine
Director for the Center for Weight and Metabolic Health. Dr. Pannain's research focuses
on the interplay between sleep and meal timing, obesity, glucose homeostasis, and
appetite regulation. More recently, she has been conducting clinical trials with novel
anti-obesity drugs.
Check the activity agenda
Wednesday, June 26, 2024
• Room 1 - Alfredo Halpern
14:15-15:45
SESSION: CIRCADIAN RYTHMS IN OBESITY
Abstracts - 129049: FEMALE MICE LACKING LIVER ADRENOCEPTOR ALPHA-1B ARE MORE SUSCEPTIBLE TO OBESITY - Presenter: Anisia Silva
Experimental models of Time restricted feeding
Impact of Sleep Duration and Meal Timing on Weight Loss and Obesity
Meal timing and its relationship with obesity and food intake
Discussion
Coordinator: Jose Donato Junior (SP)
Abstracts - 129049: FEMALE MICE LACKING LIVER ADRENOCEPTOR ALPHA-1B ARE MORE SUSCEPTIBLE TO OBESITY - Presenter: Anisia Silva
Experimental models of Time restricted feeding
Speaker: Gabriel Anhe (SP)
Impact of Sleep Duration and Meal Timing on Weight Loss and Obesity
Speaker: Silvana Pannain (United States)
Meal timing and its relationship with obesity and food intake
Speaker: Cibele Aparecida Crispim (SP)
Discussion
• Room 2 - John Waterlow
10:15-12:15
OPENING COURSES: MANAGING DIFFICULT CASES IN OBESITY
Intolerant and irresponsive to GLP-1 agonist
Extreme internalized stigma
Multiple comorbidities
BMI over 50kg/m²
Discussion
Coordinator: Jacqueline Rizzolli (RS)
Coordinator: Luiz Fellipe Carvalho Viola (MT)
Intolerant and irresponsive to GLP-1 agonist
Speaker: Cintia Cercato (SP)
Extreme internalized stigma
Speaker: Stuart Flint (United Kingdom)
Multiple comorbidities
Speaker: Silvana Pannain (United States)
BMI over 50kg/m²
Speaker: Marcio C. Mancini (SP)
Discussion
Thursday, June 27, 2024
• Room 1 - Alfredo Halpern
14:00-15:30
SESSION: HETEROGENEITY IN RESPONSES TO OBESITY TREATMENT
Abstracts - 129737: INCREASING GLP1-RA EFFICACY BY TARGETING NON-CODING RNA: A COMBINATORY APPROACH TO DEVELOP A MORE EFFECTIVE THERAPEUTIC PARADIGM - Presenter: Riccardo Panella
Predictors of weight loss in incretin-based therapies
What have we learned about the role of genetics in predicting response to obesity interventions?
Energy compensation, metabolic adaptation and physical activity
Discussion
Coordinator: Bruno Geloneze (SP)
Coordinator: Silvana Pannain (United States)
Abstracts - 129737: INCREASING GLP1-RA EFFICACY BY TARGETING NON-CODING RNA: A COMBINATORY APPROACH TO DEVELOP A MORE EFFECTIVE THERAPEUTIC PARADIGM - Presenter: Riccardo Panella
Predictors of weight loss in incretin-based therapies
Speaker: Deborah B. Horn (United States)
What have we learned about the role of genetics in predicting response to obesity interventions?
Speaker: Fernando Gerchman (RS)
Energy compensation, metabolic adaptation and physical activity
Speaker: Kevin D. Hall (United States)
Discussion
Venue
Centro de Convenções Frei Caneca
R. Frei Caneca, 569 - Bela Vista,
São Paulo - SP, 01307-001
R. Frei Caneca, 569 - Bela Vista,
São Paulo - SP, 01307-001
website ACCOMMODATION
PROMOTED BY
MANAGEMENT
Tourism Agency
DIAMOND SPONSOR
GOLD SPONSOR
BRONZE SPONSOR
SPONSOR
